Our current partners
CiMaas develops immunotherapy for cancer by optimally engaging the immune system. Dendritic cell vaccines, NK cells are enhanced by monoclonal antibodies.
|Neuroplast develops therapeutic strategies interfering with the various processes leading to neurodegeneration, by reducing inflammation and increasing neuroplasticity, an unmet need in many idiopathic, traumatic and ischemic neurodegenerative disorders.|
|Eyegle BV will develop and commercialise topical drug delivery device based solutions to treat ophthalmic diseases.|
Xilloc Medical BV
|Xilloc Medical provide patient specfic implants to reconstruct parts of the human's skeleton.|
RegMed XB. Regenerative medicine aims to restore degenerated, diseased or damaged tissues and organs, thereby increasing vital functioning and reducing the cost of healthcare. RegMed XB brings together multiple health foundations, top scientists, entrepreneurs and governments to cooperatively tackle ambitious challenges in regenerative medicine.